Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexRUT P/E- EPS (ttm)-6.64 Insider Own3.47% Shs Outstand14.66M Perf Week1.66%
Market Cap259.52M Forward P/E154.09 EPS next Y0.12 Insider Trans0.00% Shs Float14.14M Perf Month-28.20%
Income-97.52M PEG- EPS next Q-0.23 Inst Own89.63% Short Float3.60% Perf Quarter-31.05%
Sales164.17M P/S1.58 EPS this Y-381.67% Inst Trans-1.49% Short Ratio5.80 Perf Half Y-30.92%
Book/sh12.24 P/B1.45 EPS next Y107.96% ROA-34.86% Short Interest0.51M Perf Year-20.57%
Cash/sh4.26 P/C4.16 EPS next 5Y20.00% ROE-43.31% 52W Range16.00 - 29.11 Perf YTD-21.80%
Dividend Est.- P/FCF- EPS past 5Y- ROI-47.55% 52W High-39.14% Beta0.89
Dividend TTM- Quick Ratio3.78 Sales past 5Y9.62% Gross Margin48.59% 52W Low10.75% ATR (14)0.74
Dividend Ex-Date- Current Ratio5.34 EPS Y/Y TTM-295.83% Oper. Margin-19.13% RSI (14)37.82 Volatility2.87% 6.48%
Employees357 Debt/Eq0.15 Sales Y/Y TTM0.52% Profit Margin-59.40% Recom1.00 Target Price26.50
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q-350.90% Payout- Rel Volume0.48 Prev Close17.72
Sales Surprise-7.91% EPS Surprise-377.78% Sales Q/Q-6.54% EarningsOct 31 BMO Avg Volume87.68K Price17.72
SMA203.26% SMA50-18.05% SMA200-28.51% Trades Volume41,635 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-01-24Reiterated Barrington Research Outperform $37 → $25
Aug-14-23Upgrade Barrington Research Mkt Perform → Outperform $24
Mar-07-23Downgrade Barrington Research Outperform → Mkt Perform
Nov-09-22Upgrade Barrington Research Mkt Perform → Outperform $31
Oct-14-22Resumed Stephens Equal-Weight $26
Mar-09-22Downgrade Stephens Overweight → Equal-Weight $35
Mar-09-22Downgrade Barrington Research Outperform → Mkt Perform
Nov-16-21Initiated Stephens Overweight $55
Jul-16-21Initiated UBS Neutral $46
Dec-16-20Upgrade Barrington Research Mkt Perform → Outperform $43
Nov-22-24 04:16PM
Nov-01-24 03:07AM
Oct-31-24 11:00AM
08:25AM
07:18AM
07:05AM Loading…
07:05AM
07:00AM
Oct-30-24 09:19AM
Oct-17-24 04:01PM
Oct-09-24 06:04PM
Oct-04-24 04:01PM
Sep-09-24 04:45PM
Aug-15-24 04:01PM
Aug-09-24 07:41AM
Aug-08-24 06:35PM
05:27PM Loading…
05:27PM
04:05PM
Aug-05-24 04:01PM
Jul-25-24 09:00AM
Jul-16-24 07:19AM
Jul-11-24 08:30AM
Jul-01-24 10:35AM
Jun-07-24 04:01PM
May-28-24 04:05PM
May-09-24 12:22PM
10:59AM
04:07AM
May-08-24 08:57PM
05:40PM
04:08PM
04:05PM Loading…
04:05PM
May-03-24 04:01PM
Apr-18-24 04:01PM
Apr-02-24 08:00AM
Mar-16-24 03:15PM
Mar-14-24 08:18AM
Mar-13-24 04:47PM
04:05PM
Mar-08-24 04:01PM
Feb-27-24 04:01PM
Feb-13-24 09:00AM
Nov-28-23 09:00AM
Nov-07-23 04:05PM
Nov-05-23 02:26PM
Nov-03-23 09:43AM
Nov-02-23 06:11PM
05:00PM
04:05PM
Oct-10-23 09:00AM
Oct-04-23 07:18AM
Oct-03-23 09:11AM
Sep-19-23 09:00AM
09:00AM
Sep-15-23 07:44PM
04:01PM
Sep-12-23 09:00AM
Sep-01-23 06:51PM
09:35AM
Aug-31-23 12:00PM
09:35AM
Aug-22-23 07:22AM
Aug-17-23 06:20PM
11:02AM
Aug-14-23 09:59AM
Aug-11-23 07:07AM
Aug-09-23 09:03AM
Aug-08-23 06:55PM
05:40PM
04:05PM
Aug-03-23 07:33PM
Jul-20-23 04:05PM
Jul-12-23 09:00AM
Jun-21-23 08:00PM
May-30-23 04:05PM
May-15-23 09:19AM
May-09-23 07:15PM
06:08PM
04:05PM
Apr-26-23 08:00PM
Apr-19-23 11:32AM
08:30AM
Apr-13-23 05:44PM
05:00PM
Apr-12-23 09:00AM
Apr-03-23 09:00AM
Mar-27-23 04:55PM
04:19PM
08:55AM
Mar-20-23 06:15PM
02:00PM
Mar-18-23 10:08AM
08:41AM
Mar-15-23 04:01PM
Mar-08-23 10:00AM
07:21AM
Mar-07-23 09:52AM
Mar-06-23 05:45PM
04:41PM
04:05PM
Feb-28-23 09:00AM
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nunes AnneSVP, Chief Operations OfficerOct 01 '24Option Exercise0.002,491014,211Oct 04 04:06 PM
Blanchard Cheryl RPresident, CEO, DirectorMar 11 '24Option Exercise0.0064,4800166,228Mar 12 08:04 PM
Colleran DavidEVP, General Counsel, Corp SecMar 11 '24Option Exercise0.0016,809035,245Mar 12 08:03 PM
Nunes AnneSVP, Chief Operations OfficerMar 11 '24Option Exercise0.005,856011,838Mar 12 08:02 PM
Levitz Michael LEVP, CFO, TreasurerMar 11 '24Option Exercise0.0019,201049,565Mar 12 08:01 PM